Dr Judith Jay, MD in Briarcliff Manor, NY - Otolaryngology

Dr Judith Jay, MD is a Otolaryngology physician based in Briarcliff Manor, New York. Dr Judith Jay is licensed to practice in New York (license number 146030-2) and her current practice location is 425 N State Rd, Briarcliff Manor, New York. She can be reached at her office (for appointments etc.) via phone at (914) 945-0505.

NPI number for Dr Judith Jay is 1922079649 and her current mailing address is 425 N State Rd, Briarcliff Manor, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1922079649.

Contact Information

	Dr Judith Jay, MD
	425 N State Rd, Briarcliff Manor, NY 10510-1469
	(914) 945-0505
	(914) 945-0828

Physician's Profile

Full Name	Dr Judith Jay
Gender	Female
Speciality	Otolaryngology
Location	425 N State Rd, Briarcliff Manor, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1922079649
Provider Enumeration Date: 01/30/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Judith Jay such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922079649	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	146030-2 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Judith Jay is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Judith Jay, MD 425 N State Rd, Briarcliff Manor, NY 10510-1469 Ph: (914) 945-0505	Dr Judith Jay, MD 425 N State Rd, Briarcliff Manor, NY 10510-1469 Ph: (914) 945-0505

News Archive

Emergent Group board sets revised payment date for special and regular annual dividends

Emergent Group Inc., a leading provider of mobile medical lasers and surgical equipment, today said that its Board of Directors has set a revised payment date of January 4, 2011 for the special and regular annual dividends totaling $0.90 per common share that it previously announced on December 7th for shareholders of record as of December 17, 2010.

Liquid biopsy provides physicians with up-to-date information about patient's cancer

A team of researchers, including scientists from the Translational Genomics Research Institute, has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient's cancer evolves and responds to treatment.

NanoViricides files FluCide pre-IND briefing document with the FDA

NanoViricides, Inc. announced today that it has submitted a pre-IND briefing document to the US FDA. This submission provides the required information for the Company's highly effective anti-influenza drug candidate, FluCide, in support of a pre-IND Meeting.

Optimum blood vitamin D levels to reduce risk of major medical events

In testing older patients' blood vitamin D levels, there's uncertainty about where the dividing line falls between enough and not enough. The threshold amount has become controversial as several scientific societies set different targets.

Dr Judith Jay, MD - Otolaryngology in Briarcliff Manor, NY